Dare Bioscience DARE
NASDAQ DARE
$0.85 +0.03 (+3.69%)
As of: Sep 30, 2026 · 10:15 AM EDT

Dare Bioscience (DARE) Current Leases (2025 - 2026)

Updated

Dare Bioscience's Current Leases was $149,374 in Q2 2026, down 91.8% from $1.83 million a year earlier.

Analysis

Dare Bioscience (DARE) Current Leases (2025 - 2026) Analysis & Trends

At the end of FY2025, Current Leases at Dare Bioscience came in at $1.49 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn -
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 274.00 Mn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -2.32 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn -
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Dare Bioscience 11.38 Mn -54.09 Mn -132,343.00 149,374.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 149,374.00
Dec 31, 2025 1.49 Mn
Sep 30, 2025 1.87 Mn
Jun 30, 2025 1.83 Mn
Mar 31, 2025 1.75 Mn
API Access

Dare Bioscience Current Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-leases&ticker=DARE&period=max&api_key=YOUR_API_KEY